Who are Patch Biosciences's investors?

Patch Biosciences's investors include Andreessen Horowitz, Section 32, Casdin Capital.

When was Patch Biosciences founded?

Patch Biosciences was founded in 2020.

Where is Patch Biosciences headquartered?

Patch Biosciences is headquartered in Albany, New York, United States.

What industry is Patch Biosciences in?

Patch Biosciences operates in Healthcare.

How many employees does Patch Biosciences have?

Patch Biosciences has 1-10 employees.

Patch Biosciences

Acquired

Machine-designed sequences for safer, more effective gene therapy

Albany, United States · Founded 2020

Healthcare

Headquarters: Albany, New York
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: patch.bio
Last Round: SeedSep 2020
Rounds: 1

About

Patch Biosciences was a synthetic biology and machine learning company that built an AI platform for sequence design to engineer more effective, specific, and durable genetic medicines. The company developed machine learning models and downstream assays to engineer synthetic promoters and untranslated regions (UTRs) for gene therapy, cell therapy, and RNA therapeutics applications. Backed by Andreessen Horowitz Bio+Health, Casdin Capital, and S32, Patch was acquired by Ginkgo Bioworks in February 2024, with its AI/ML capabilities integrated into Ginkgo's genetic medicine platform to accelerate programs for biopharma partners including Pfizer and Biogen.

Summary

Patch Biosciences is a Healthcare company based in Albany, United States, founded in 2020. Its most recent funding was a Seed round in Sep 2020. Investors include Andreessen Horowitz, Section 32 and Casdin Capital.